P47 Capecitabine, oxaliplatin and bevacizumab as first line treatment for elderly patients with metastatic colorectal cancer: a multicenter phase II trial from Hellenic Oncology Research Group
Titel:
P47 Capecitabine, oxaliplatin and bevacizumab as first line treatment for elderly patients with metastatic colorectal cancer: a multicenter phase II trial from Hellenic Oncology Research Group
Auteur:
Vamvakas, L. Prinari, A. Karampeazis, A. Androulakis, N. Giassas, S. Xenidis, N. Polyzos, A. Athanasiadis, A. Georgoulias, V. Souglakos, J.